跳至主要内容
临床试验/NCT05544604
NCT05544604已完成不适用

Effect of Motor Cortex Versus Insula Cortical Targets Stimulation Using Concentric Electrode Transcranial Direct Current Stimulation on Chronic Post-mastectomy Pain; a Randomized Sham Controlled Study

South Egypt Cancer Institute1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2020年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
chronic postmastectomy pain relief

研究概览

简要总结

This study is designed to evaluate the effect of two concentric electrode transcranial direct current stimulation over the primary motor cortex versus insular cortical targets in post mastectomy neuropathic pain.

详细描述

eighty patients within age group 18-65 years old with post mastectomy neuropathic pain that are resistant to medical treatment in the form of tramadol hydrochloride 100 mg twice daily, pregabalin 75 mg twice daily and Amitriptyline 25 mg once daily for at least two months or associated with significant adverse effect from medication will be involved in this study.

twenty patients will be randomly allocated into one of the study designed groups using serially numbered opaque closed envelopes. Each patient will be placed in the appropriate group after opening the corresponding sealed envelope. The patient will receive one of the following interventions either:

  • active tDCS (2 mA) targeting the primary motor cortex of the contralateral side of the pain for 20 minute duration for five sessions in five consecutive days (one session /day),
  • sham tDCS over the primary motor cortex in the same stimulation parameters will be used but the device will be turned off without patient knowledge after 30 seconds ,
  • active tDCS (2mA) targeting the insula of the contralateral side of the pain for 20 minute duration for five sessions in five consecutive days (one session /day),
  • sham tDCS over the insula in the same stimulation parameters will be used but the device will be turned off without patient knowledge after 30 seconds.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

盲法说明

serially numbered opaque closed envelopes. Each patient will be placed in the appropriate group after opening the corresponding sealed envelope

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •eighty patients within age group 18-65 years old with post mastectomy neuropathic pain that are resistant to medical treatment in the form of tramadol hydrochloride 100 mg twice daily, pregabalin 75 mg twice daily and Amitriptyline 25 mg once daily for at least two months or associated with significant adverse effect from medication will be involved in this study.

排除标准

  • •We will exclude patients with intracranial metallic devices or with pacemakers or any other device. We also exclude those with extensive myocardial ischemia and those known to have epilepsy

研究组 & 干预措施

group 1: active primary motor cortex stimulation

Active Comparator

active tDCS (2 mA) targeting the primary motor cortex of the contralateral side of the pain for 20 minute duration for five sessions in five consecutive days (one session /day)

干预措施: Transcranial direct current stimulation (Device)

group 2 : sham primary motor cortex stimulation

Sham Comparator

sham tDCS over the primary motor cortex in the same stimulation parameters will be used but the device will be turned off without patient knowledge after 30 seconds.

干预措施: Transcranial direct current stimulation (Device)

group 3 : active insula stimulation

Active Comparator

active tDCS (2 mA) targeting the insula of the contralateral side of the pain for 20 minute duration for five sessions in five consecutive days (one session /day)

干预措施: Transcranial direct current stimulation (Device)

group 4 : sham insula stimulation

Sham Comparator

sham tDCS over the insula in the same stimulation parameters will be used but the device will be turned off without patient knowledge after 30 seconds.

干预措施: Transcranial direct current stimulation (Device)

结局指标

主要结局

chronic postmastectomy pain relief

时间窗: VAS monitoring one month later

pain relief on the VAS 1 month later

chronic postmastectomy pain relief

时间窗: VAS monitoring after 5th session

pain relief on the VAS after the 5th session

chronic postmastectomy pain relief

时间窗: VAS monitoring after 15 days

pain relief on the VAS after 15 days

次要结局

  • VDS, LANSS and depression symptoms by HAM-D(VDS, LANSS and depression symptoms by HAM-D after one month)
  • VDS, LANSS and depression symptoms by HAM-D(VDS, LANSS and depression symptoms by HAM-D after 5th session)
  • VDS, LANSS and depression symptoms by HAM-D(VDS, LANSS and depression symptoms by HAM-D after 15 days)

研究者

发起方
South Egypt Cancer Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohannad Ahmed Mohamed

Principal Investigator

South Egypt Cancer Institute

研究点 (1)

Loading locations...

相似试验